Search all medical codes

Adverse effect of antineoplastic and immunosuppressive drugs, initial encounter

ICD10CM code

Medical Policies and Guidelines for Adverse effect of antineoplastic and immunosuppressive drugs, initial encounter

Related policies from health plans

Genotype Testing for Individual Genetic Polymorphisms to Determine Drug-Metabolizer
Selected Injectable 5HT3 Antiemetic Agents
CG-GENE-11 Genotype Testing for Individual Genetic Polymorphisms to Determine Drug-Metabolizer Status
Pedmark (sodium thiosulfate) (PG133)
Varubi (rolapitant) (PG178)
Transthoracic Echocardiography in Adults - (0510)
Transthoracic Echocardiography in Adults - (0510)
Transthoracic Echocardiography in Children - (0523)

Similar Codes


ICD10CM codes

T45.1X5A - Adverse effect of antineoplastic and immunosuppressive drugs, initial encounter
T45.1X5D - Adverse effect of antineoplastic and immunosuppressive drugs, subsequent encounter
T45.1X5 - Adverse effect of antineoplastic and immunosuppressive drugs
T45.1X5S - Adverse effect of antineoplastic and immunosuppressive drugs, sequela
T45.1X6A - Underdosing of antineoplastic and immunosuppressive drugs, initial encounter
T45.1X4A - Poisoning by antineoplastic and immunosuppressive drugs, undetermined, initial encounter
T45.1X1A - Poisoning by antineoplastic and immunosuppressive drugs, accidental (unintentional), initial encount
T45.8X5A - Adverse effect of other primarily systemic and hematological agents, initial encounter
T45.1X6D - Underdosing of antineoplastic and immunosuppressive drugs, subsequent encounter
T45.1X3A - Poisoning by antineoplastic and immunosuppressive drugs, assault, initial encounter

HCPCS codes

J7599 - Immunosuppressive drug, not otherwise classified
J9999 - Not otherwise classified, antineoplastic drugs
Q0510 - Pharmacy supply fee for initial immunosuppressive drug(s), first month following transplant
G8927 - Adjuvant chemotherapy referred, prescribed or previously received for ajcc stage iii, colon cancer
J9055 - Injection, cetuximab, 10 mg
S9359 - Home infusion therapy, anti-tumor necrosis factor intravenous therapy; (e.g., infliximab); administr
G9842 - Patient has metastatic disease at diagnosis
J9000 - Injection, doxorubicin hydrochloride, 10 mg
D9610 - THERAPEUTIC PARENTERAL DRUG
Q2050 - Injection, doxorubicin hydrochloride, liposomal, not otherwise specified, 10 mg

CPT4 codes

96402 - Chemotherapy administration, subcutaneous or intramuscular; hormonal anti-neoplastic
96401 - Chemotherapy administration, subcutaneous or intramuscular; non-hormonal anti-neoplastic
96549 - Unlisted chemotherapy procedure
96409 - Chemotherapy administration; intravenous, push technique, single or initial substance/drug
96405 - Chemotherapy administration; intralesional, up to and including 7 lesions
96406 - Chemotherapy administration; intralesional, more than 7 lesions
80193 - Leflunomide
96411 - Chemotherapy administration; intravenous, push technique, each additional substance/drug (List separ
4037F - Influenza immunization ordered or administered (COPD, PV, CKD, ESRD)(IBD)
88239 - Tissue culture for neoplastic disorders; solid tumor